跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-verapamil
首页
药物
R-verapamil
R-verapamil
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
Crystal forms of verapamil hydrochloride
US 9950995 B2
申请人: CENTER LABORATORIES INC
优先权: 2014
CN
US
3 件公开
Method of treating hyperglycemia
US 9980935 B2
申请人: CENTER LABORATORIES INC
优先权: 2016
CN
US
3 件公开
US 10639292 B2
申请人: CENTER LABORATORIES INC
优先权: 2018
US
Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
US 2003092765 A1
申请人: KELLY JOHN
优先权: 2002
US
3 件公开
Methods for treating at least one condition having MT1 receptor, 5HT2B receptor, and L-type calcium channel activity
US 2008045603 A1
申请人: DEVANE JOHN
优先权: 2007
US
2 件公开
AGENT FOR TREATING ATRIAL FIBRILLATION
US 2009247572 A1
申请人: WADA KOICHI
优先权: 2005
US
COMPOSITIONS AND METHODS HAVING MT1 RECEPTOR ACTIVITY
US 2009023814 A1
申请人: AGI THERAPEUTICS RES LTD
优先权: 2008
US
Substituted quinolone methyl alcohol compound having activity of reversing drug resistance of tumor cell and synthesis method and application of substituted quinolone methyl alcohol compound
CN 108610327 A
申请人: UNIV HENAN NORMAL
优先权: 2018
CN
Hederagenin C-2 heterocyclic oxime ester derivative as well as preparation method and application thereof
CN 121449674 A
申请人: UNIV YANTAI
优先权: 2025
CN
Hederagenin C-23 heterocyclic ester derivative as well as preparation method and application thereof
CN 121574172 A
申请人: UNIV YANTAI
优先权: 2025
CN
药物
反馈
